Please assess the completion status of the following clinical trial:

Trial Title: Chloroprocaine Spinal Anesthesia for Cervical Cerclage (CP Spinal)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA I and II women~* 18-45 yrs old~* Singleton pregnancy~* Cervical cerclage 1st or 2nd trimester of pregnancy undergoing with spinal anesthesia~* Height 150 - 180 cm~* BMI ≤ 40 kg/m2.~Exclusion Criteria:~* Any contraindication to neuraxial anesthesia (history of neurologic disease (e.g., multiple sclerosis, spinal stenosis, central or peripheral neuropathy)~* Pre-existing/chronic back pain~* Ester local anesthetic allergy, PABA allergy~* History of atypical cholinesterase (CP is metabolized by cholinesterase)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Chloroprocaine (CP) (Type: EXPERIMENTAL): Patients in CP group will receive 3% 2-chloroprocaine 50 mg (1.67 ml) and fentanyl 15 mcg (0.3 ml)
- Bupivacaine (BUP) (Type: ACTIVE_COMPARATOR): Patients in BUP group will receive hyperbaric 0.75% bupivacaine 9 mg (1.4 ml), with fentanyl 15 mcg (0.3 ml), with saline (0.3 ml) to bring the volume to \~ 2 ml

Based on this trial design, predict the completion outcome and termination type (if applicable).